Related by context. All words. (Click for frequent words.) 80 Gastrointestinal Cancers Symposium 78 Hematology ASH Annual Meeting 77 Hematology Annual Meeting 77 Annual Scientific Sessions 76 nd Annual Meeting 76 Therapeutics TCT scientific 76 ASCO GI 74 AACR Meeting 74 ASCO Annual Meeting 74 AHA Scientific Sessions 74 AACR San Antonio 74 Annual Transcatheter Cardiovascular 74 Clinical Oncology Annual Meeting 73 EORTC NCI AACR Symposium 73 CTRC AACR San Antonio 73 Annual ICAAC 73 ICAAC IDSA 73 ASTRO Annual Meeting 72 annual Transcatheter Cardiovascular 72 AACR #st Annual Meeting 72 Digestive Disease Week DDW 72 Hematology Meeting 72 ICAAC 72 Society CTOS 72 st Annual Meeting 72 Genitourinary Cancers Symposium 72 Therapeutics TCT 72 AACR #nd Annual Meeting 71 Connective Tissue Oncology 71 Breast Cancer Symposium 71 Endocrine Society ENDO 71 AUA Annual Meeting 71 EORTC NCI AACR 71 ISPOR 71 AASLD Meeting 71 AACR NCI EORTC 71 ACR ARHP 70 #nd Annual Meeting 70 Biological Therapy 70 Cancers Symposium 70 ADA Scientific Sessions 70 Late Breaker 70 Prostate Cancer Symposium 70 AAN Annual Meeting 70 Symposium SABCS 70 ECCMID 69 UEGW 69 International Myeloma Workshop 69 Clinical Oncology ASCO Annual 69 Related Disorders ICAD 69 ECTRIMS 68 Medical Oncology ESMO 68 SABCS 68 CROI 68 Cancer iSBTc 68 AAPS Annual Meeting 68 ASGT 68 #st Annual Meeting 68 AABB Annual Meeting 68 Opportunistic Infections CROI 68 GTCbio 68 Molecular Targets 68 Hematology ASH 68 #th Annual Interscience 68 Gastrointestinal Cancer 68 Clinical Virology Symposium 68 ASCO Genitourinary Cancers Symposium 68 Antimicrobial Agents 67 Scientific Sessions 67 Breast Cancer Symposium SABCS 67 Transcatheter Cardiovascular Therapeutics TCT 67 Digestive Diseases Week 67 Molecular Medicine Tri 67 AASLD 67 Oral Presentations 67 DIA Annual Meeting 67 Infectious Diseases ECCMID 67 Malignant Lymphoma 67 Endocrine Society Annual Meeting 67 Neurology Annual Meeting 66 International Papillomavirus 66 Chemotherapy ICAAC 66 BIOCOM Investor Conference 66 Digestive Disease Week 66 Liver EASL 66 ASMS Conference 66 AACR Annual Meeting 66 ASCO Breast Cancer 66 AACR Frontiers 66 Cancer Therapeutic 66 Rheumatology ACR Annual 66 ECCO ESMO 66 #th Interscience Conference 66 Annual BIO 66 Clinical Trial Results 66 Gastroenterology ACG Annual 66 Poster Discussion 66 Midyear Clinical Meeting 66 Scientific Session 65 Poster Presentations 65 Endocrine Society #st 65 ASCO GU 65 HFSA Annual 65 Annual Interscience Conference 65 Targeted Therapies 65 European CanCer Organisation ECCO 65 Brentuximab Vedotin SGN 65 ACR ARHP Annual 65 ESMO 65 Endocrine Society #nd 65 Nephrology Renal Week 65 VEITHsymposium 65 Cambridge Healthtech Institute 65 BIO InvestorForum 65 EORTC NCI 65 HCV Protease Inhibitor 65 #rd Annual CTRC 65 Retroviruses 65 Endovascular Therapy ISET 65 ERA EDTA 65 Metastatic Melanoma 64 ORAL Sync 64 Vascular Annual Meeting 64 Vascular Biology ATVB 64 Chicago Multidisciplinary Symposium 64 Alzheimer Disease ICAD 64 Immunology Annual Meeting 64 League Against Rheumatism 64 Association EHA 64 Microbiology ASM 64 #nd EORTC NCI 64 MOZOBIL 64 entitled Synergistic 64 Oligonucleotide Therapeutics Society 64 Cardiostim 64 Oncology ASTRO 64 Postgraduate Course 64 Poster Presentation 64 EFNS 64 USpella 64 Phase III Trial 64 Cardiovascular Therapeutics 64 ASBMR 64 Canaccord Adams Hepatitis C 63 Rheumatology Annual 63 Combination REOLYSIN R 63 Phase 2b Clinical Trial 63 Spine Arthroplasty Society 63 America HFSA 63 AHIMA Convention 63 AACC Annual Meeting 63 Opportunistic Infections 63 Haemostasis ISTH 63 EASL 63 Chronic Lymphocytic Leukemia 63 Transcatheter Cardiovascular Therapeutics 63 ASCO 63 AAO HNSF Annual Meeting 63 Annual AIFA 63 Related Viruses 63 Drug Formulation 63 Systemic Sclerosis 63 Urology EAU 63 assessing T DM1 63 Retrovirus Conference 63 Gene Therapy ASGT 63 Hsp# Inhibitor 62 Targeted Anticancer Therapies 62 Hematology ASH Meeting 62 Phase 2a Study 62 AACR IASLC Joint 62 ABRF 62 ARVO 62 Malignant Mesothelioma 62 Antibody Therapeutics 62 Acute Heart Failure 62 Podium Presentation 62 Delcath Phase III 62 DDW ® 62 ExL Pharma 62 Clinical Trial Data 62 ASCO Gastrointestinal Cancers Symposium 62 PROSTVAC TM 62 th Interscience Conference 62 KRN# 62 Clinical Oncology ASCO 62 Needham Biotechnology 62 Venereology EADV 62 Selective Cardiac Myosin Activator 62 Preclinical Data 62 ASM Biodefense 62 Hedgehog Pathway Inhibitor 62 Antiviral Research 62 Oral Fingolimod 62 Annual Meeting 62 Neuro Oncology SNO 62 EuroPCR 62 Therapeutic Targets 62 Annual LD MICRO 62 IL# PE#QQR 61 Hematology 61 Heart Failure Society 61 EULAR Annual 61 Selective Cardiac Myosin 61 AACR 61 Focal Therapy 61 Printable slides 61 San Antonio Breast Cancer 61 Phase #b/#a clinical 61 Oral Presentation 61 Arteriosclerosis Thrombosis 61 IASLC 61 ACC.# 61 LD MICRO Conference 61 AACR symposium 61 Myelodysplastic Syndromes 61 Advanced Neuroendocrine Tumors 61 Antithrombotic 61 Gynecologic Cancer Society 61 Annual Canaccord Adams 61 Gaylord Palms Hotel 61 Refractory Angina 61 Neoplasia 61 Therapeutic Radiology 61 Clinical Oncologists 61 Therapeutics Roundtable 61 Fifth Decennial International 61 Hormone Refractory Prostate Cancer 61 Phase 2a Trial 61 Phase III Clinical Trial 61 II Clinical Trial 61 Phase Ib study 61 Novel Therapeutics 61 Scientific Meeting 61 YONDELIS 61 Pediatric Academic Societies PAS 61 Multiple Sclerosis ECTRIMS 61 SAEM Annual Meeting 61 HIV Pathogenesis 61 Clinical Microbiology 61 Randomized Phase 61 TXPO 61 ESTRO 61 HDL Selective Delipidation 61 Hematological Malignancies 61 Neurology AAN 61 NSTI Nanotech 61 Relapsed Multiple Myeloma 61 SCAI Annual 61 Pharmaceutical Scientists AAPS 61 Autoimmunity 61 Elagolix 61 BiTE R 61 Randomized Phase III 61 Clinical Trials Update 61 Applied Spectroscopy 61 Vicriviroc 61 AAAAI Annual Meeting 60 Endovascular Therapy 60 Lung Cancer IASLC 60 Interscience Conference 60 Atrial Fibrillation Symposium 60 Patient Treated 60 Clinical Oncology Gastrointestinal Cancers 60 Advanced Renal Cell 60 BioProcess International 60 Glufosfamide 60 GVAX ® 60 GTCbio 3rd 60 Cystic Fibrosis Conference NACFC 60 Tesetaxel 60 Annual CTRC AACR 60 Pediatric Academic Society 60 NASDAQ CYTK announced 60 VEITHsymposium ™ 60 Radiation Oncology ASTRO 60 ongoing Phase 1b 60 Metabolic Disorders 60 www.asco.org 60 Personalized Immunotherapy 60 Inflammatory Arthritis 60 Novel Therapies 60 Romidepsin 60 CRLX# 60 NASDAQ SLXP today 60 PreCISe 60 CTRC AACR 60 Minimally Invasive Gynecology 60 Breaking Clinical Trials 60 In3 WEST 60 Medtech Insight Prestigious 60 ECNP Congress 60 Cachexia 60 Cancer Immunotherapy 60 ISTH 60 Cardiovascular Disease Epidemiology 60 Poster Session 60 Annual EuroMeeting 60 Prolongs Survival 60 HORIZONS AMI 60 Abstract Accepted 60 www.aacr.org 60 Interventions SCAI 60 TORISEL TM 60 ERA D2C Convention 60 Cell Transplant 60 Ocular Diseases 60 Molecular Markers 60 sorafenib tablets 60 Clinical Oncology ASCO Gastrointestinal 60 RNAi Therapeutic 60 Liver Meeting 60 Canaccord Genuity Growth 60 Monoclonal Antibodies 60 PROactive Study 60 Annual Institutional Investor 60 Pediatric Academic Societies 60 ThermoDox ® clinical 60 Small Fuel Cells 60 Vaccine Adjuvant 60 Biodefense Vaccines 60 Phase III Trials 60 Ozarelix 60 Therapeutic Radiation 60 transthyretin TTR mediated amyloidosis 60 TG MV 60 Gastrointestinal Oncology 60 BCIRG 60 Carfilzomib 60 Announces Poster Presentations 60 Dendritic Cells 60 Keystone Symposia 60 Annual BioPartnering Europe 60 Biologic Therapy 60 Cloretazine ® 60 Bazedoxifene 60 sipuleucel T 60 Phase Ib II 59 Immunotherapeutic 59 Pivotal Phase III 59 ASCO abstract 59 SCCHN 59 ECNP 59 ENDEAVOR IV 59 IEEE Photovoltaic Specialists 59 CLEO QELS 59 BioCentury Future Leaders 59 Gynecologic Investigation 59 Castration Resistant Prostate Cancer 59 Trodusquemine MSI 59 ARVO Annual Meeting 59 Completes Patient Enrollment 59 Recurrent Chest Wall 59 Autoimmune Diseases 59 Patient Enrollment 59 BIO VentureForum East 59 INSPIRE Trial Phase III 59 See CLINICAL PHARMACOLOGY 59 LD Micro 59 Liver Diseases AASLD 59 Chronic Lymphocytic Leukemia CLL 59 Anticancer Drugs 59 FOLOTYN ® 59 Sipuleucel T 59 Solid Tumors 59 Preclinical Efficacy 59 ENDO 59 Neuropathic Pain 59 HDAC Inhibitor 59 EFORT Congress 59 Biodetection Technologies 59 LSE ASM 59 Phase #/#a trial 59 ganetespib 59 EUROGIN 59 Therapeutic Vaccine 59 Double Blind Placebo 59 Antiepileptic Drugs 59 ELACYT 59 Phase 2a Clinical Trial 59 Preclinical Study 59 Windhover Therapeutic Area 59 registrational Phase 59 Stent Thrombosis 59 Scrip Awards 59 including eniluracil ADH 59 Drug Candidate 59 Meets Primary Endpoint 59 Nordic ACTI 59 AAEP Convention 59 recurrent glioma 59 First Patient Enrolled 59 Immunomedics Announces 59 SUCCEED trial 59 Myoblast 59 Patients Treated With 59 iSBTc 59 Influenza Vaccines 59 Potent Antiviral Activity 59 Initiate Phase 59 CCX# 59 Treating Chronic 59 Advanced Melanoma 59 abstracts summarizing 59 trastuzumab DM1 T DM1 59 Annual HIMSS 59 Pirfenidone 59 Therapeutic Approaches 59 Oral Insulin Capsule 59 Phase IIb Clinical Trial 59 J.P. Morgan Healthcare 59 SA FC# 59 Investigational Drug 59 Presents Positive 59 Cutaneous T 58 Cell Biology ASCB 58 JAK2 Inhibitor 58 Zenvia Phase III 58 WLSA Convergence Summit 58 In3 EUROPE 58 Human Genetics ASHG 58 EACTS 58 SAWC WHS 58 HIMSS Annual 58 Liver Disease AASLD 58 ENDEAVOR III 58 Sangamo BioSciences Announces 58 Female Urology 58 Canaccord Adams Musculoskeletal 58 metastatic castration resistant 58 non nucleoside inhibitor 58 ISPE Annual Meeting 58 System Pharmacists ASHP 58 Prospective Multicenter 58 Renal Cell Carcinoma 58 Aflibercept 58 ® DDW 58 Cardiology Scientific Sessions 58 PROSTASCINT R 58 Novel Antibiotic 58 Initiates Clinical Trial 58 INCB# [001] 58 Renal Cancer 58 EORTC 58 Belimumab 58 Interventional Radiological Society 58 & OTO EXPO 58 Diabetes EASD 58 Study Evaluating 58 ACUITY trial 58 Heska Announces 58 Severe Sepsis 58 Abstract Number 58 DIA EuroMeeting 58 VIVUS Qnexa 58 Ophthalmology ARVO 58 Controlled Release 58 Interventional Therapies 58 Tumor Microenvironment 58 Inc. Nasdaq IMGN 58 essential thrombocythemia ET 58 Pooled Analysis 58 Emerging Therapies 58 Shows Efficacy 58 depsipeptide 58 Two Upcoming Investor 58 Aplidin R 58 Semafore Pharmaceuticals 58 Annual NewsMakers 58 AACR EORTC NCI 58 EADV 58 CYT# potent vascular disrupting 58 dose escalation clinical 58 BR.# 58 Genta Incorporated OTCBB GETA 58 Anti Tumor Activity 58 Urocortin 2 58 Serious Infections 58 Inflammatory Bowel Diseases 58 Cardiotoxicity 58 In3 East 58 oral proteasome inhibitor 58 Phase Ib Clinical Trial 58 BRIM2 58 BioContact Quebec 58 Varespladib 58 Vitro Activity 58 PNP inhibitor 58 Presents Preclinical Data 58 ALS MND 58 Safinamide 58 Metastatic Colorectal Cancer 58 Traficet EN 58 Annual OneMedForum 58 Investigational Compound 58 HuMax CD4 58 MEK Inhibitor 58 Chemotherapy ICAAC Infectious Diseases 58 Dr. Pingpank 58 Phase III AFFIRM 58 Oncology ESTRO 58 BRIM3 58 RECORD1 58 Initiated Phase 58 NASDAQ INHX 58 Romiplostim 58 Gynecological Cancer 58 Annual JMP Securities 58 Relapsing Multiple Sclerosis 58 Amrubicin 58 Interventional Radiology SIR 58 CSCMP Annual Conference 58 HUPO 58 Initiates Phase III 58 Anticancer Drug 58 Phase #/#a 58 Cloretazine R 58 Colorectal Cancer CRC 58 Cardiovascular Horizons 58 Asbestos Awareness Conference 58 AGBT 58 CALGB # [002] 58 Antitumor Activity 58 Anti Angiogenesis 58 LibiGel ® 58 Natalizumab 58 acute PAO 58 abstr 58 DASISION 58 Atypical Hemolytic Uremic Syndrome 58 Drugs Affecting Lipid 58 HQK 58 antibody blinatumomab MT#/MEDI-# 58 SMi 58 Completes Enrollment 58 Phase III ALLEGRO 58 ASGCT 58 Antiviral Therapy 57 RANK Ligand inhibitor 57 Phase Ib clinical 57 Cellular Therapy ISCT 57 Diabetic Macular Edema 57 Pivotal Phase 57 PROTECT AF 57 ALN TTR 57 Capsule Endoscopy 57 LBH# 57 Advanced Colorectal Cancer 57 lexidronam injection 57 alvespimycin 57 Complete Remission 57 Immune Mediated 57 Novel Oral 57 Val HeFT 57 Guidelines Recommend 57 Biennial Meeting 57 Pivotal Clinical Trial 57 Nasdaq INCY announced 57 Pre RELAX AHF 57 National Bereavement Teleconference 57 Randomized Study 57 Deforolimus 57 Nasdaq REGN 57 oncolytic virus therapies 57 Experimental Biology EB 57 Velcade bortezomib 57 Vaccine Immunology 57 By NamNewsNetwork Jan 57 By Liam Hunn 57 pan HDAC inhibitor 57 Therapeutic Antibodies 57 mitogen activated ERK kinase 57 LabAutomation 57 ANN INTERN MED 57 LibiGel testosterone gel 57 Lysosomal Disease Network 57 PANVAC VF 57 evaluating mipomersen 57 Outcomes Research ISPOR 57 Mineral Research ASBMR 57 Valopicitabine 57 Therapeutic Advances 57 Aryplase 57 Cancer Therapeutics 57 Peer Reviewed Journal 57 Cancer Therapies 57 PEG SN# 57 AEG# 57 number NCT# ClinicalTrials.gov 57 ASA CSSA SSSA 57 HIMSS# Interoperability Showcase 57 ESCRS 57 huC# DM4 57 forodesine 57 Therapeutic Vaccines 57 LymphoStat B 57 PROLARIS 57 Inhalation Solution 57 Dr. Gulfo 57 LungSign TM 57 Preclinical Models 57 www.durect.com 57 Neck Surgery Foundation 57 Sybase TechWave 57 Stem Cell Research ISSCR 57 American Thoracic Society 57 Multilateral Initiative 57 evaluating tivozanib 57 www.micromet inc.com 57 Cancer AACR NCI 57 Talabostat 57 Soft Tissue Sarcoma 57 Cardiovascular Interventions 57 & Immunology AAAAI 57 perifosine KRX 57 histone deacetylase HDAC inhibitor 57 Xelox 57 Gastroenterology ACG 57 orally inhaled migraine 57 Hypertension ASH 57 SPIRIT IV 57 RNAi Therapeutics 57 Lung Transplantation 57 randomized controlled Phase 57 Therapeutic Radiation Oncology 57 GW# [003] 57 Cancer Vaccines 57 Surgical Mesh 57 Kinase Inhibitor 57 SYN# 57 Multiple Myeloma MM 57 GASTRO 57 Clinical Dermatology 57 AAICAD 57 Telik Announces 57 Medtech Insight Investment 57 Bortezomib 57 Acute Myocardial Infarction 57 DermTech International 57 #:#-# [033] 57 HCV SPRINT 57 Tanespimycin 57 Xcytrin R 57 ularitide 57 Pivotal Trial 57 Arch Neurol 57 Dose Escalation 57 Decitabine 57 oral FTY# 57 Nicotine Vaccine 57 OneMedPlace Finance Forum 57 Nasdaq ENZN 57 SAWC 57 Inc. Nasdaq OPTR 57 Hepatocellular Carcinoma 57 By Matt Akersten 57 AIR2 Trial 57 clevidipine 57 Biomarker Study 57 NanoEurope 57 Phase 2b Trial 57 Initiates Enrollment 57 phase IIa clinical 57 Dalbavancin 57 novel VDA molecule 57 Zarnestra 57 CTI Nasdaq 57 Pivotal Study 57 Hodgkin lymphoma HL 57 AIDS Vaccine 57 Pulmonary Arterial Hypertension 57 Initiates Phase II 57 metastatic CRC 57 BioPharm America 57 Randomized Phase II 57 Demonstrate Significant 57 Sapacitabine 57 Pemetrexed 57 Pandemic Influenza Vaccines 57 Tumor Response 57 BiTE ® 57 Integrative Oncology 57 Investigational Treatment 57 BHIVA 57 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 57 Patient Enrolment 57 ICR XChange Investor 57 MT# MEDI 57 Molecular Origins 57 EGS# 57 Overactive Bladder OAB 57 Memgen 57 COPIC Energy 57 SCTE Cable Tec EXPO 57 Previously Treated 57 Gastroenterology Week UEGW 57 Systemic Delivery 57 OvaRex R 57 Kahalalide F 57 Reports Preclinical Data 57 Lupus Nephritis 57 Annual Westergaard SmallCap 57 Acute Ischemic Stroke 57 European CanCer Organisation 57 Mass Spectrometry ASMS 57 Phase IIb Trial 57 Vaccine Protects Against 57 Daclizumab 57 vivo preclinical 57 Novel Small Molecule 57 OMP #M# 57 Monoclonal antibody 57 Clinical Chemistry AACC 57 Archexin 57 Hygiene ASTMH 57 Inc. Nasdaq AVRX 57 NABTT 57 Shows Promise Against 57 Ophthalmology ARVO Annual Meeting 57 Prostate AdenoCarcinoma Treatment 57 CUSTOM III 57 Renal Cell Cancer 57 AVERROES 57 By Brian Lofrumento 56 Lung Cancer Trial 56 BIO Windhover 56 Annual NAMIC 56 Announces Presentation 56 Phase III ThermoDox 56 By DJ Abisalih 56 Hepatitis C Virus 56 By Taimur Asad 56 ExTRACT TIMI 56 developer Antisoma plc 56 Gastrointestinal Stromal Tumors 56 R roscovitine 56 Temodar ® 56 Breast Surgeons 56 Randomized Double Blind 56 Endoscopic Surgeons SAGES 56 Virulizin ® 56 Crit Rev 56 HFSA 56 Bladder Cancer 56 ZFP Therapeutic 56 Genitourinary Cancer 56 Thiovir 56 Antiviral Activity 56 Successfully Completes Phase 56 AAGL 56 CLARITY study 56 preclinical efficacy 56 journal Antimicrobial Agents 56 Cancer Patients Treated 56 Phase III Pivotal 56 CTAP# Capsules 56 Movement Disorder 56 OHR/AVR# 56 CIMZIA TM certolizumab pegol 56 Ocular Pharmacology 56 Gynecologic Oncologists 56 XL# SAR# 56 Christina Radish Posted 56 Phase III Clinical Trials 56 Cardiology ESC Congress 56 Biopharmaceutical Manufacturing 56 Ocrelizumab 56 Sue Deyoe ~ 56 Protein Therapeutics 56 CHEST 56 Tumor Progression 56 Anti Infective Drugs 56 Novalis Circle 56 Am J Epidemiol 56 OncoVex 56 SOUTHWESTERN SHOWCASE Investor 56 Newly Diagnosed Multiple Myeloma 56 Room #AB [002] 56 AlwaysOn OnMedia NYC 56 Thrombolytic Therapy 56 pertuzumab 56 Research IADR 56 J Clin Oncol 56 Chronic Hepatitis C 56 ThermoDox R 56 neratinib 56 Medtrade 56 Adjuvant Breast Cancer 56 NEUVENGE 56 IND Filing 56 th Annual Interscience 56 PITTCON 56 fosbretabulin 56 DermaVir Patch 56 Diana Haecker ~ 56 Photocure ASA 56 Fuel Cell Seminar 56 EXPLORE Xa 56 Certican 56 By AAyles 56 Lung Cancer WCLC 56 DU #b 56 By Frankie Genchi 56 Demonstrates Significant 56 Adefovir 56 Ambrisentan 56 PSMA ADC 56 RGB # 56 MASS Opportunities 56 Oncologic 56 Pharmacoeconomics 56 Neck Cancer 56 Epileptology 56 Ceflatonin R 56 Webcast Discussion 56 unique alkylating agent 56 Drug Eluting 56 Tyrosine Kinase Inhibitors 56 ASN Renal Week 56 www.hematology.org 56 R lenalidomide 56 oral ridaforolimus 56 Cardiac Techniques 56 TACI Ig 56 CEQ# 56 targeting CD# 56 LUMINATE 56 Annual Canaccord Genuity 56 HDL Mimetic Peptide 56 EVEREST II 56 SoftScan R 56 Select Biosciences 56 Immunosuppression 56 EOquin TM 56 http:/www.vivus.com 56 Randomized Clinical Trials 56 EUROPEAN BIOTECHNICA AWARD 56 Needham Growth Conference 56 Midatlantic Employers Association 56 rALLy clinical trial 56 Clinical Efficacy 56 MEND CABG 56 Astralis Ltd. 56 CIRSE 56 metastatic renal cell 56 Disease Modifying 56 EULAR 56 Newly Diagnosed Patients 56 radezolid 56 IRX 2 56 Kaufman Bros. Investor 56 recurrent GBM 56 AA Amyloidosis 56 Pharmacoeconomic 56 Novel Therapeutic 56 HIMSS# Annual Conference 56 Coronary Revascularization 56 Mark Joyella #:# [002] 56 NO# [002] 56 rALLy trial 56 Myocet 56 Vaccine Adjuvants 56 AVAX 56 Adult Stem Cell Therapy 56 NASDAQ PCYC 56 rALLy 56 First Patient Dosed 56 International OARSI 56 Canaccord Adams Healthy Living 56 Craig Hallum Institutional Investor 56 Needham Growth Stock 56 GRNCM1 56 ABCSG 56 Phase 2a trial 56 Twentieth Annual 56 Inflammatory Diseases 56 Solorel TM 56 Randomized Double blind 56 Breast Surgeons ASBS 56 galiximab 56 midstage clinical 56 PAINWeek 56 Hypertension ESH 56 ASLA Annual Meeting 56 HIMSS# Annual 56 MASCC 56 Phase 2b Study 56 Nexavar sorafenib 56 Breast Brachytherapy 56 Phase 2b RESTORE CLI 56 HIF PHI 56 By wildouble Posted 56 Cellular Therapy 56 SPIE Photonics West 56 Zemplar Capsules 56 HepaSphere 56 metastatic hormone refractory 56 Bucindolol 56 Drug Shows Promise 56 EMBLEM TM 56 Immunogenicity 56 Ocular Inflammation 56 CRMD# 56 fidaxomicin Phase 3 56 seliciclib CYC# 56 Pyridorin 56 Plaque Psoriasis 56 Cinacalcet 56 Respiratory Society 56 TASKi2 56 BioPartnering Europe 56 Inc. Nasdaq ATHX 56 Proc Am Soc 56 Colorectal Cancer Patients 56 Platelet Inhibition 56 Ranolazine 56 Adjuvant Treatment 56 Retina Specialists ASRS 56 J Natl Cancer Inst 56 Microplasmin 56 Long Term Efficacy 56 Interventional Oncology 56 Maven Semantic 56 BioDevice Partnering 56 REG2 56 Genetic Basis 56 Inc. Nasdaq AMLN 56 VitiGam 56 Protease Inhibitor 56 Pemphigus Vulgaris 56 Tibotec BVBA 56 Presents Preclinical 56 Deke Marston 56 Canaccord Adams Global 56 Receives Orphan Drug Designation 56 ADVANCE PD 56 delafloxacin 56 GITA Annual 56 Phase III ADT 56 pralatrexate injection folate analogue 56 Adjunctive Therapy 56 Mike Washlesky #:# [002] 56 Systemic Lupus Erythematosus 56 Microalbuminuria 55 Demonstrates Efficacy 55 Biotech Showcase 55 EXPAREL ™ 55 ASCO Abstract 55 Outpatient Setting 55 Owen Vater 55 www.pranabio.com 55 Wound Healing Society 55 CALGB 55 Nasdaq SNSS 55 Frozen Shoulder syndrome 55 Rotavirus Vaccine 55 resistant hormone refractory 55 Andy Hemmington 55 Patient Outcomes 55 Tuberculosis Vaccine 55 C# BioVentures Conference 55 Anesthesiologists Annual Meeting 55 LymphoStat B TM 55 Initiates Clinical 55 http:/www.hematology.org 55 WaterSmart Innovations Conference 55 enzastaurin 55 Acute Decompensated Heart Failure 55 Telbivudine 55 By mumbrella · 55 Trandolapril 55 By Tim Beissmann 55 pharmacokinetic PK study 55 Cardiology ESC 55 Intersolar Munich 55 Plenary Session 55 CAMMS# 55 Tyrosine Kinase Inhibitor 55 omacetaxine mepesuccinate 55 CHAMPION PCI 55 ID NCT# 55 Thromboembolic 55 Improved Survival 55 www.rxipharma.com 55 rd Annual 55 Endourology 55 Multicenter Randomized 55 GlassBuild America 55 HORIZONS AMI trial 55 Inflammatory Disease 55 ThinkEquity Partners Growth 55 Cotara ® 55 Dacogen injection 55 Cancer Stem Cells 55 hormone refractory metastatic prostate 55 vidofludimus 55 Blood Cancers 55 Kibow Biotech 55 LT NS#